{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T05:18:27Z","timestamp":1791695907897,"version":"4.3.4"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:title>\n                    A\n                    <jats:sc>BSTRACT<\/jats:sc>\n                  <\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Biobehavioral surveys confirm that HIV prevalence is high or \u2018concentrated\u2019 among \u2018key populations\u2019 (KPs) who have unprotected sexual contacts with multiple partners or who engage in injecting drug use. These populations include female sex workers (FSW), men who have sex with men (MSM), hijra\/transgender (TG), and people who inject drugs (PWID). Antiretroviral therapy is offered under the program of National AIDS Control to Seropositive population at the designated center. Other than the stigma of being HIV positive, there is an additional factor present among these groups of people hindering their uptake of antiretroviral therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims:<\/jats:title>\n                    <jats:p>To identify and quantify the factors causing poor uptake of ART (antiretroviral therapy) among high risk group of subjects receiving antiretroviral therapy, namely, female sex workers (FEW) and intravenous drug users (IDU). A concurrent parallel design of mixed methodology was conducted with integration of the two arms at analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Material and Method:<\/jats:title>\n                    <jats:p>\n                      The quantitative arm involves a retrospective cohort analysis of group on ART having \u201cexposure\u201d defined as\n                      <jats:italic toggle=\"yes\">high risk behavior for<\/jats:italic>\n                      a period of 1 year. High-risk behavior constituted of exposure involved in commercial sex work and those exposed to intravenous drug usage. The comparator arm was sex-matched cohort who were sero-positive and on ART but did not have an \u201cexposure\u201d to defined high-risk behavior practice for a period of 1 year. The qualitative arm constituted of development of a grounded theory based on thematic analysis from coded transcripts.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Result:<\/jats:title>\n                    <jats:p>Time taken to travel and expenditure incurred therein added with long waiting time compounded with loss of daily wage (reiterated in both arms) emerged to be the most prominent factor.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Monetary incentive for travel, single window service rapid service and process to access drugs from any center (via a central registration system if possible) may be useful.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jfmpc.jfmpc_1533_24","type":"journal-article","created":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T13:00:14Z","timestamp":1748696414000},"page":"1657-1661","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["A mix methodology study to compile the factors contributing towards poor uptake of antiretroviral therapy among high-risk groups: Female sex workers, people with intravenous drug use on opiod substitution therapy"],"prefix":"10.4103","volume":"14","author":[{"given":"Debjani","family":"Sengupta","sequence":"first","affiliation":[{"name":"Department of Community Medicine, Calcutta National Medical College, Kolkata, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Archi","family":"Chandra","sequence":"additional","affiliation":[{"name":"Community Medicine, Jagannath Gupta Institute of Medical Sciences, Budgebudge, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Upasana","family":"Poddar","sequence":"additional","affiliation":[{"name":"Community Medicine, Prafulla Chandra Sen Govt Medical College and Hospital, Arambag, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Biswas","sequence":"additional","affiliation":[{"name":"Department of Community Medicine, Medical College Kolkata, Kolkata, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pramit","family":"Ghosh","sequence":"additional","affiliation":[{"name":"Scientist E ICMR National Institute for Research in Bacterial Infections, Kolkata, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arkaprovo","family":"Pal","sequence":"additional","affiliation":[{"name":"Community Medicine, Scientist B (Medical), ICMR \u2013CAM, Kolkata, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandipta","family":"Chakraborty","sequence":"additional","affiliation":[{"name":"Project Manager (Scientific) (Medical Research Planning and Cordination), ICMR \u2013 PMABHIM Project, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debjani","family":"Guchait","sequence":"additional","affiliation":[{"name":"Senior Resident CMOH Office, 24 Parganas South, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,5,31]]},"reference":[{"key":"R3-20250602","doi-asserted-by":"crossref","first-page":"e0203262","DOI":"10.1371\/journal.pone.0203262","article-title":"\u201cThey don't like us\u2026.\u201d:Barriers to antiretroviral and opioid substitution therapy among homeless HIV positive people who inject drugs in Delhi:A mixed method study","volume":"13","author":"Kumar","year":"2018","journal-title":"PLoS One"},{"key":"R4-20250602","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1097\/QAD.0000000000001458","article-title":"Impact of opioid substitution therapy on the HIV prevention benefit of antiretroviral therapy for people who inject drugs","volume":"31","author":"Mukandavire","year":"2017","journal-title":"AIDS"},{"key":"R5-20250602","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.4103\/jfmpc.jfmpc_40_19","article-title":"Determinants contributing for poor adherence to antiretroviral therapy:A hospital record-based study in Balasore, Odisha","volume":"8","author":"Gupta","year":"2019","journal-title":"J Fam Med Prim Care"},{"key":"R6-20250602","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3390\/tropicalmed5010041","article-title":"What are the barriers for uptake of antiretroviral therapy in HIV-infected tuberculosis patients?A mixed-methods study from Ayeyawady Region, Myanmar","volume":"5","author":"Aung","year":"2020","journal-title":"Trop Med Infect Dis"},{"key":"R7-20250602","doi-asserted-by":"crossref","first-page":"377","DOI":"10.2989\/16085906.2016.1255652","article-title":"HIV care and treatment experiences among female sex workers living with HIV in sub-Saharan Africa:A systematic review","volume":"15","author":"Lancaster","year":"2016","journal-title":"Afr J AIDS Res"},{"key":"R8-20250602","doi-asserted-by":"crossref","first-page":"456","DOI":"10.4314\/ahs.v22i1.54","article-title":"Factors affecting adherence to anti-retroviral therapy among women attending HIV clinic of a tertiary health institution in SouthEastern, Nigeria","volume":"22","author":"Opara","year":"2022","journal-title":"Afr Health Sci"},{"key":"R9-20250602","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1080\/17441692.2020.1858137","article-title":"ART uptake and adherence among female sex workers (FSW) globally:A scoping review","volume":"17","author":"Glick","year":"2022","journal-title":"Glob Public Health"},{"key":"R10-20250602","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1093\/eurpub\/ckad008","article-title":"HIV treatment, antiretroviral adherence and AIDS mortality in people who inject drugs:A scoping review","volume":"33","author":"Uusk\u00fcla","year":"2023","journal-title":"Eur J Public Health"},{"key":"R11-20250602","doi-asserted-by":"crossref","first-page":"108218","DOI":"10.1016\/j.drugalcdep.2020.108218","article-title":"ART uptake and adherence among women who use drugs globally:A scoping review","volume":"215","author":"Glick","year":"2020","journal-title":"Drug Alcohol Depend"},{"key":"R12-20250602","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1093\/cid\/ciw416","article-title":"Impact of opioid substitution therapy on antiretroviral therapy outcomes:A systematic review and meta-analysis","volume":"63","author":"Low","year":"2016","journal-title":"Clin Infect Dis"},{"key":"R13-20250602","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s12981-021-00395-3","article-title":"Barriers to and enablers of uptake of antiretroviral therapy in integrated HIV and tuberculosis treatment programmes in sub-Saharan Africa:A systematic review and meta-analysis","volume":"18","author":"Kadia","year":"2021","journal-title":"AIDS Res Ther"}],"container-title":["Journal of Family Medicine and Primary Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jfmpc.jfmpc_1533_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:15:29Z","timestamp":1787836529000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jfmpc.jfmpc_1533_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":11,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/jfmpc.jfmpc_1533_24","relation":{},"ISSN":["2249-4863","2278-7135"],"issn-type":[{"value":"2249-4863","type":"print"},{"value":"2278-7135","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"2024-09-04","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-10-14","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}